Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × AZD1390 × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 2 Sarcoma 1 Meningeal Neoplasms 1 Inhibition, Psychological 1 Hereditary Sensory and Autonomic Neuropathies 1 Glioma 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Radiotherapy 10 Specimen Handling 7 Gemcitabine 7 Doxorubicin 7 Cyclophosphamide 7 pembrolizumab 6 Temozolomide 6 Magnetic Resonance Spectroscopy 6 Biopsy 6 pazopanib 5 Ifosfamide 5 X-Rays 4 Trabectedin 4 Surgical Procedures, Operative 4 Radiation 4 Nivolumab 4 tazemetostat 3 talimogene laherparepvec 3 fludarabine 3 Vincristine 3 Standard of Care 3 Phantoms, Imaging 3 Irinotecan 3 Docetaxel 3 Blood Specimen Collection 3 selpercatinib 2 selinexor 2 regorafenib 2 olaparib 2 liposomal doxorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05116254 2026-01-23

SADDRIN-1

The Netherlands Cancer Institute

Phase 1 Terminated

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡